Webinar
After-market aftermath: Methods and processes to monitor product performance
Catch the latest updates and discuss the goals of Post-Market Surveillance (PMS) and Post-Market Clinical Follow-up (PMCF) in this two-part webinar series.
Part 1: The aim of Post-Market Surveillance
16 September
Watch Now On-Demand
Part 2: The importance of Post-Market Clinical Follow-Up
23 September
10:00 EDT/16:00 CEST
30 min session
Amplexor’s two-part webinar series in collaboration with Seyed Khorashahi will cover the key elements of Post-Market Surveillance and the purpose behind Post-Market Clinical Follow-Up.
PMS is a crucial step for manufacturers in the pharmaceutical and medical fields. Collecting data and reporting its analysis is part of quality & regulatory compliance and helps monitor the performance of commercialized products available on the market. It is of utmost importance for this to be followed by PMCF, to ensure safety and top-notch performance.
Agenda
Part 1: Post-Market Surveillance (30 min session)
Watch Now On-Demand
RCA’s Seyed Khorashahi will cover the difference between Post Market Surveillance (PMS) and vigilance, the methods and processes used to monitor product performance and the overall PMS requirements.
Part 2: Post-Market Clinical Follow-Up (30 min session)
23 September 10:00 EDT/16:00 CEST
Seyed will join us again to delve into why Post-Market Clinical Follow-up is a crucial step in ensuring safety and quality of new released medical grade products, by making sure the benefits outweigh the risks.
Meet the Speaker
REGISTRATION
After-market aftermath: Methods and processes to monitor product performance
Part 1: The aim of Post-Market Surveillance (30 min session)
Watch Now On-Demand
Part 2: The importance of Post-Market Clinical Follow-Up (30 min session)
23 September 10:00 EDT/16:00 CEST